Jul 9, 2026 08:30AM
Jul 9, 2026 08:30AM
Jun 30, 2026 08:31AM
Jun 30, 2026 08:30AM
Jun 23, 2026 08:31AM
Jun 23, 2026 08:30AM
Jun 18, 2026 08:31AM Quoin Pharma forms Japan subsidiary to advance QRX003 commercialization
Jun 18, 2026 08:30AM
Jun 4, 2026 08:31AM
Jun 4, 2026 08:30AM
Jun 2, 2026 08:31AM
Jun 2, 2026 08:30AM
May 7, 2026 08:30AM
Apr 28, 2026 12:02PM CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
Apr 28, 2026 08:32AM
Apr 28, 2026 08:30AM
Mar 26, 2026 08:30AM
Mar 25, 2026 08:31AM
Mar 25, 2026 08:30AM
Mar 11, 2026 08:30AM
Mar 11, 2026 08:30AM Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome
Jan 27, 2026 08:31AM
Jan 27, 2026 08:30AM
Jan 20, 2026 08:30AM
Nov 11, 2025 08:31AM
Nov 11, 2025 08:30AM
Nov 6, 2025 08:30AM
Oct 21, 2025 08:30AM FDA grants orphan drug designation to Quoin's QRX003 for Netherton Syndrome
Oct 21, 2025 08:30AM
Oct 10, 2025 09:25AM
Oct 10, 2025 09:24AM
Aug 7, 2025 08:30AM
Jun 26, 2025 08:30AM
Jun 24, 2025 08:34AM
Jun 24, 2025 08:30AM Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome
May 22, 2025 07:31AM
May 22, 2025 07:30AM
May 13, 2025 08:00AM
Apr 10, 2025 07:30AM
Mar 25, 2025 07:31AM
Mar 25, 2025 07:30AM
Mar 13, 2025 07:30AM Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
Mar 4, 2025 07:30AM
Mar 4, 2025 07:30AM
Feb 4, 2025 07:30AM
Jan 23, 2025 08:30AM
Jan 23, 2025 05:30AM
Jan 14, 2025 08:34AM
Jan 14, 2025 08:30AM Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Jan 7, 2025 02:29PM

325,894 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All